Edition:
United States

Natera Inc (NTRA.OQ)

NTRA.OQ on NASDAQ Stock Exchange Global Select Market

16.07USD
4:00pm EDT
Change (% chg)

$2.03 (+14.46%)
Prev Close
$14.04
Open
$13.95
Day's High
$16.12
Day's Low
$13.80
Volume
401,152
Avg. Vol
55,921
52-wk High
$16.12
52-wk Low
$7.80

Chart for

About

Natera, Inc. is a diagnostics company. The Company is engaged in the discovery, development and commercialization of genetic testing services. It offers Panorama Non-Invasive Prenatal Test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother; Horizon Carrier Screening to determine carrier... (more)

Overall

Beta: --
Market Cap(Mil.): $794.25
Shares Outstanding(Mil.): 54.51
Dividend: --
Yield (%): --

Financials

  NTRA.OQ Industry Sector
P/E (TTM): -- 41.24 33.54
EPS (TTM): -2.48 -- --
ROI: -135.06 14.38 13.09
ROE: -381.76 17.60 15.10

BRIEF-Natera Q1 Loss Per Share $0.61

* Q1 EARNINGS PER SHARE VIEW $-0.59 -- THOMSON REUTERS I/B/E/S

May 08 2018

BRIEF-Natera Reports Q4 Loss Per Share $0.87

* NATERA REPORTS FOURTH QUARTER AND FISCAL YEAR 2017 FINANCIAL RESULTS

Mar 13 2018

Natera settles U.S. billing probe over prenatal gene tests for $11.4 mln

Diagnostics company Natera Inc has agreed to pay nearly $11.4 million to resolve claims it improperly billed government healthcare programs for its prenatal genetic test, the U.S. Justice Department said.

Mar 12 2018

Earnings vs. Estimates